Update on adult attention-deficit/hyperactivity disorder.
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent and highly morbid neurobehavioral disorder afflicting children, adolescents, and adults throughout the world. This article discusses the clinical assessment of adult ADHD, reviews the results of recent adult ADHD treatment studies with an emphasis on medications currently approved by the US Food and Drug Administration, and discusses the clinical management and monitoring of ADHD pharmacotherapy.
Hammerness
Paul
P
Clinical and Research Program in Pediatric Psychopharmacology, 185 Alewife Brook Parkway, Suite 2000, Cambridge, MA 02138, USA. phammerness@partners.org
Surman
Craig
C
Miller
Katherine
K
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male
C090411:Adderall; D000662:Amphetamines; D000697:Central Nervous System Stimulants